|
One of the world's most experienced developers of cancer drugs
Dr. Daniel Von Hoff serves as Professor of Pathology, Molecular and Cellular Biology, and Director of the Arizona Health Science Center 's Cancer Therapeutic Programs at the University of Arizona in Tucson. He is also Chief Scientific Officer for US Oncology. Dr. Von Hoff's major interest is in the development of new anticancer agents. He and his laboratory are concentrating on the discovery of new targets in pancreatic cancer. Dr. Von Hoff has published more than 490 papers, 122 book chapters, and more than 830 abstracts. He is also the past President of the American Association for Cancer Research, a Fellow of the American College of Physicians, and a member and past board member of the American Society of Clinical Oncology. | 